EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessment of the Fractures Risk in Patients with Nephrolithiasis

Oleg Nikitin, Illia Kordubailo, Olha Nishkumay, Mike K.S. Chan, Michelle B.F. Wong, Dmytro Klokol, Oksana Zaytseva, Hennadii Reznikov

SSP Modern Pharmacy and Medicine · 13.10.2025 · 5 (4) · 30

DOI: 10.53933/0waq5n36 ↗

Kurz gefasst

Fachartikel in der Zeitschrift SSP Modern Pharmacy and Medicine, online erschienen am 13.10.2025. Verfasst von Oleg Nikitin und 7 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kidney stone disease is a common polyetiological urological disease that is also often combined with bone mineral density (BMD) disorders. Currently, no common recommendations exist for managing patients with comorbid conditions such as osteoporosis and kidney stone disease. Therefore, the aim of the study was to evaluate bone mineral density, the trabecular bone score index, fracture risk assessment tool and trabecular bone score-adjusted fracture risk assessment tool risk in patients with nephrolithiasis. Materials and methods. The study was conducted based on the Urology Department of the O.O. Bogomolets National Medical University, Kyiv (Oleksandrivska Clinical Hospital, Kyiv), Department of Urology, Kyiv Regional Clinical Hospital, Kyiv, Ukraine. 80 patients took part in the study, among them 15 men and 65 women. All patients were divided into 2 groups. The 1st group with somatic diseases in remission without kidney stone disease and those without exclusion criteria (32 patients, women 31 (96.9%), men – 1 (3.1%), age 64 [58-72] y.o. The II group was introduced patients with kidney stone disease (48 patients, women – 34 (70.8%), men – 14 (29.2%), age 55.5[51.5-62.5] y.o. Results. Comparative analysis of X-ray densitometry did not establish a difference between bone mineral density in the comparison groups. However, the trabecular bone score was lower in patients with kidney stone disease (p=0.02). When evaluating anamnestic data in patients with the presence of nephrolithiasis, no differences were found in the frequency of fractures in the past (p

Zitieren

APA

Nikitin, O., Kordubailo, I., Nishkumay, O., Chan, M. K., Wong, M. B., Klokol, D., Zaytseva, O., & Reznikov, H. (2025). Assessment of the Fractures Risk in Patients with Nephrolithiasis. SSP Modern Pharmacy and Medicine, 5(4), 30. https://doi.org/10.53933/0waq5n36

Vancouver

Nikitin O, Kordubailo I, Nishkumay O, Chan MK, Wong MB, Klokol D, et al. Assessment of the Fractures Risk in Patients with Nephrolithiasis. SSP Modern Pharmacy and Medicine. 2025;5(4):30. doi:10.53933/0waq5n36

BibTeX
@article{Nikitin2025,
  author = {Nikitin, Oleg and Kordubailo, Illia and Nishkumay, Olha and Chan, Mike K.S. and Wong, Michelle B.F. and Klokol, Dmytro and Zaytseva, Oksana and Reznikov, Hennadii},
  title = {Assessment of the Fractures Risk in Patients with Nephrolithiasis},
  journal = {SSP Modern Pharmacy and Medicine},
  year = {2025},
  volume = {5},
  number = {4},
  pages = {30},
  doi = {10.53933/0waq5n36}
}
Kostenlos starten →